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Introduction
Postprandial hyperglycemia is an independent risk factor for cardiovascular disease morbidity and mortality (Cavalot et al. 2011; The DECODE group 1999 Nakagami and DECODA Study Group 2004) . Even acute postprandial hyperglycemia and acute fluctuation in blood glucose concentration induce vascular endothelial dysfunction (Kawano et al. 1999; Williams et al. 1998) , platelet activation (Sakamoto et al. 2000) , oxidative stress, and inflammation (Esposito et al. 2002) . Therefore, it is very important to elucidate the causes of postprandial hyperglycemia to prevent cardiovascular diseases.
Postprandial hyperglycemia would depend on the content of the diet; specifically, an acute increase in blood glucose concentration may be induced by short-term intake of a eucaloric low-carbohydrate/high-fat diet (LCHF, >70% fats). Several studies using an oral glucose tolerance test (OGTT) in non-diabetic individuals have demonstrated that short-term eucaloric LCHF leads to an excessive increase in postprandial glucose concentration and aggravation of postprandial glucose metabolism. Pehleman et al. (2005) reported that compared with a control diet, a 2-day intake of LCHF resulted in a greater increase in postprandial blood glucose and insulin concentrations. Moreover, Numao et al. (2012 Numao et al. ( , 2013 demonstrated that compared with a control diet, a 3-day intake of LCHF resulted in a greater D r a f t 4 increase in postprandial blood glucose concentration and decrease in first-phase insulin secretion. Despite these findings, the dose-response relationship of short-term intake of carbohydrates and fats with aggravation of postprandial glucose metabolism has not been investigated.
Atherosclerosis is usually initiated by endothelial activation that releases soluble forms of adhesion molecules (Mah and Bruno 2012) . Therefore, some circulating soluble adhesion molecules, such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), can be biomarkers of endothelial dysfunction. In healthy individuals as well as in diabetic patients, circulating ICAM-1 and VCAM-1 concentrations have been reported to increase during hyperglycemia (Ceriello et al. 2004; Derosa et al. 2010; Marfella et al. 2000) . This suggests that hyperglycemia may elicit endothelial activation and development of atherosclerosis. However, the effects of aggravation of postprandial glucose metabolism induced by short-term dietary fat intake on circulating adhesion molecules have been unclear.
The purpose of this study was to determine the effects of short-term dietary fat content on postprandial glucose metabolism and circulating adhesion molecules in healthy males. D r a f t 5
Methods and materials

Participants
Seven healthy non-diabetic young males (age: 26 ± 1 years; height: 179 ± 1 cm; fasting glucose concentration: <126 mg/dl) participated in this study. We believe that males are more susceptible to diet-related alterations in postprandial glucose metabolism, because of higher incidences of diabetes and impaired glucose tolerance in males than in females (Cowie et al. 2009; Hennninger et al. 2015; Soriguer et al. 2012) . Because of the clinical implications, we recruited only males as participants in the present study. None of the participants had regular exercise habits and history of any metabolic and cardiovascular diseases. All participants were non-smokers and were not on any medication or supplements. The purpose, design, and risks of this study were explained to all participants and each provided written informed consent. The study conformed to the principles outlined in the Helsinki Declaration and was approved by the ethics committee of Waseda University (2011-207).
Study protocol
Three experimental trials lasting 4 days each were administered to participants in a crossover design. These trials consisted of a 3-day intake of a control diet (C), intermediate-carbohydrate/intermediate-fat diet (ICIF), or LCHF. The order of the trials was D r a f t 6 randomized in each participant. The wash-out period was set at >1 week. One day before each trial, the participants were instructed to eat a uniform diet and to take their evening meal before 21:00; thereafter, they were asked to refrain from consuming any food except water.
The next morning (day 1), the participants arrived at the laboratory at 09:00 after an overnight fast (>12 h). After a 30-min rest period in the supine position, blood sample was taken to measure baseline metabolites and hormone concentrations. In addition, body mass, fat mass (FM), and fat-free mass (FFM) were measured using the impedance method (InnerScan BC-520; Tanita, Tokyo, Japan). After these measurements, the participants consumed the designated trial diets until day 3 (for 3 days).
On day 4 (after the 3-day dietary intervention) of each trial, the participants arrived at the laboratory at 09:00 after an overnight fast. Initially, body mass, FM, and FFM were measured using the impedance method (InnerScan BC-520). After a 30-min rest period in the supine position, an intravenous catheter was inserted into the antecubital vein and a blood sample was obtained. Thereafter, a 120-min meal tolerance test (MTT) was started using an experimental meal (JANEF E460F18; Kewpie Corporation, Tokyo, Japan). The experimental meal for MMT was composed of cream chicken, cracker, and pudding, with 460 kcal energy, 18.0 g protein, 18.0 g fats, and 56.5 g carbohydrates. During MTT, the participants rested D r a f t 7 supine on a bed while blood samples were drawn at 15, 30, 45, 60, 90 , and 120 min after consuming the experimental meal.
Experimental diets
The participants consumed the 3 experimental diets (C, ICIF, and LCHF) for 3 consecutive days each. The menu of these diets was prepared by a skilled nutritionist using a dietary analysis program (Eiyoukun, version 4.0; Kenpakusya, Tokyo, Japan) and was provided to the participants by the investigators. The total energy intake per day of each participant was Labour and Welfare 2010). The total energy intake per day was similar among the 3 experimental diets, whereas the percentage of fats and carbohydrates to total energy intake varied. The approximate contents of C were 10% protein, 30% fats, and 60% carbohydrates; those of ICIF were 10% protein, 50% fats, and 40% carbohydrates; and those of LCHF were 10% protein, 70% fats, and 20% carbohydrates (Table 1 ). Based on our previous studies (Numao et al. 2012 (Numao et al. , 2013 and other previous study (Pehleman et al. 2005) , the percentage of protein, fats, and carbohydrates in each experimental diet was determined as follows; first, C D r a f t 8 was set as the recommended diet with recommended quantity of nutrients (Ministry of Health Labour and Welfare, 2010) . Second, although the percentage of fat is extremely high, LCHF was set as the diet containing the percentage of fat (approximately 70%) that is likely to aggravate postprandial glucose metabolism, as seen in previous studies (Numao et al. 2012 (Numao et al. , 2013 Pehleman et al. 2005) . Finally, ICIF was set as the diet containing the percentage of fat that was intermediate between that of C and LCHF so that the dose-response relationship between percentage of fat intake and postprandial glucose metabolism could be determined within the range of C to LCHF. These diets were constant every day and were designed to be as common and as regular as possible. The participants were instructed to adhere to the provided menu, to check the food intake record, and to maintain their usual lifestyle and physical activities throughout the experiment.
Blood sampling and analysis
For analysis of glucose concentration, blood samples were collected in a 2-mL tube containing sodium fluoride, heparin sodium, and disodium ethylenediaminetetraacetate (EDTA-2Na). For analysis of insulin, free fatty acid (FFA), β-hydroxybutyric acid (β-HBA), triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDLC), alanine aminotransferase (ALT), aspartate aminotransferase (AST), ICAM-1, and VCAM-1 D r a f t 9 concentrations, blood samples were collected in an 8-mL tube containing thrombin and silica.
For analysis of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) concentrations, blood samples were collected in a 2-mL tube containing 2.5 mg EDTA, 1000 KIU aprotinin, and 20 µl dipeptidyl peptidase-4 inhibitor (Millipore, MA, USA). Blood samples in 2-mL tubes were kept on ice and centrifuged at 3000 × g for 10 min at 4°C within 30 min of collection; samples in 8-mL tubes were centrifuged at 3000 × g for 10 min at 4°C after 30 min of collection. After centrifugation, the plasma and serum obtained from each sample were transferred into plastic tubes and immediately stored at −80°C until further analysis.
Plasma glucose concentration was analyzed using an enzymatic colorimetric method [Wako Pure Chemical Industries, Osaka, Japan; intra-assay coefficient of variation (CV), <0.22%].
Serum insulin concentration was measured using electrochemiluminescence immunoassay (Roche Diagnostics, Tokyo, Japan; intra-assay CV: <1.3%). Serum FFA concentration was analyzed using an enzymatic colorimetric method (Wako Pure Chemical Industries; intra-assay CV: <0.39%). Serum β-HBA concentration was measured by an enzymatic cycling method (Kainos Laboratories, Tokyo, Japan; intra-assay CV: <0.55%). Serum TG concentration was analyzed using an enzymatic colorimetric method with a glycerol blank D r a f t 10 sample (Kyowa Medex, Tokyo, Japan; intra-assay CV, <0.82%). Serum TC and HDLC concentrations were measured by an enzymatic method (Kyowa Medex; intra-assay CV:
<0.92% and <0.52%, respectively). The concentration of low-density lipoprotein cholesterol (LDLC) was calculated according to the equation of Friedewald et al. (1972) . Serum ALT and AST concentrations were determined by the Japan Society of Clinical Chemistry transferable method (Wako Pure Chemical Industries; intra-assay CV: <0.54% and <1.87%, respectively). Serum ICAM-1 and VCAM-1 and plasma GIP and GLP-1 (7-36 and 7-37 amides) concentrations were measured by enzyme-linked immunosorbent assays (Millipore; intra-assay CV: <6.7%, <6.7%, <8.8%, and <8.0%, respectively). To eliminate inter-assay variation, samples from each participant were analyzed in the same run.
Assessment of metabolites, insulin sensitivity, and insulin secretion
Changes in the concentrations of metabolites (glucose, insulin, FFA, β-HBA, TG, GIP, GLP-1, ICAM-1, and VCAM-1) during the 120-min MTT were assessed by the incremental area under the curve (iAUC), which was calculated by the trapezoidal rule. Insulin sensitivity was assessed by the homeostasis model assessment index of insulin resistance (HOMA-IR), Matsuda index (Matsuda and DeFronzo 1999) , and oral glucose insulin sensitivity (OGIS) (Mari et al. 2001) ; first-phase insulin release was assessed by the insulinogenic and Stumvoll D r a f t index (Stumvoll et al. 2000) .
Statistical analysis
All data are represented as mean ± standard error (SE) and were tested for normality using the Kolmogorov-Smirnov test. Based on postprandial glucose response in our previous study (Numao et al. 2013 
Results
Characteristics
Body mass, BMI, %fat, FM, and FFM remained unchanged in the C, ICIF, and LCHF trials (Table 2) .
Concentrations of fasting metabolites
Fasting metabolite concentrations were shown in Table 3 . Fasting plasma glucose decreased significantly in the C, ICIF, and LCHF trials; however, this trend did not differ among the 3 trials. TG concentration decreased significantly in the LCHF trial but remained unchanged in the C and ICIF trials. FFA and β-HBA concentrations increased significantly in the LCHF trial, but remained unchanged in the C and ICIF trials. HOMA-IR, TC, HDLC, LDLC, ALT, AST, ICAM-1, and VCAM-1 remained unchanged after the 3 trials.
Concentrations of fasting hormones
Fasting hormone concentrations were shown in Table 3 . Fasting serum insulin concentrations D r a f t 13 decreased significantly in the C, ICIF, and LCHF trials (Table3), but the change did not differ among the 3 trials. GIP and GLP-1 remained unchanged after the 3 trials.
Metabolite concentrations and iAUC during MTT
The changes of the metabolite concentrations during MMT are shown in Fig. 1-3, respectively. Moreover, the iAUC of the metabolite concentrations during MMT are shown in Table 4 . The iAUC of plasma glucose concentration was significantly 56% higher in the LCHF trial than in the C trial (P = 0.009; effect size: 1.77) but did not significantly differ between the ICIF and C trials. The iAUC of plasma GIP, TG, and FFA concentrations did not differ among the 3 trials. The iAUC of serum β-HBA concentration was significantly 1075% lower in the LCHF trial than in the C trial (P = 0.027; effect size: 1.45) but did not significantly differ between the ICIF and C trials. The iAUC of serum ICAM-1 concentration did not differ among the 3 trails, whereas that of VCAM-1 concentration was significantly 344% higher in the LCHF trial than in the C trial (P = 0.044; effect size: 1.29) but did not significantly differ between the ICIF and C trials.
Hormone concentrations and iAUC during MTT
The changes of the hormone concentrations during MMT are shown in Fig. 4 , Moreover, the iAUC of the hormone concentrations during MMT are shown in Table 4 . The iAUC of serum D r a f t 14 insulin concentration did not differ significantly among the 3 trials. The iAUC of plasma GLP-1 concentration was significantly 63% higher in the LCHF trial than in the C trial (P = 0.014; effect size: 1.45) but did not differ significantly between the ICIF and C trials. Plasma GIP concentrations did not differ among the 3 trials.
Insulin sensitivity and first-phase insulin release
The Matsuda index and OGIS did not differ significantly among the C, ICIF, and LCHF trials (Table 5 ). The insulinogenic index was significantly lower in the LCHF trial than in the C trial (P = 0.044; effect size: 1.26) but did not significantly differ between the ICIF and C trials. The Stumvoll index tended to be lower in the LCHF trial than in the C trial (P = 0.20; effect size: 0.83).
Discussion
To the best of our knowledge, the present study is the first to investigate the dose-response Our results are in agreement with the results of previous studies using OGTT that reported that short-term (2-3 days) intake of eucaloric LCHF (approximately 5%-20% carbohydrates and 70%-73% fats) excessively increased postprandial glucose concentration (Numao et al. 2012 (Numao et al. , 2013 Pehleman et al. 2005 ) and suppressed first-phase insulin release (Numao et al. 2012 (Numao et al. , 2013 ) compared with a control diet (approximately 51%-62% carbohydrates and 29%-30% fats). Moreover, a previous study using intravenous glucose tolerance test demonstrated that short-term (approximately 3 days) intake of eucaloric LCHF (approximately 0% carbohydrates and 85% fats) aggravated glucose tolerance compared with a control diet (approximately 50% carbohydrates and 35% fats) (Johnson et al. 2006) . In contrast, although the response of postprandial glucose metabolism was not directly observed, previous studies using an intravenous glucose tolerance test or euglycemic hyperinsulinemic clamp (Branis et al. 2015) showed that short-term (5-7 days) intake of eucaloric ICIF (30% carbohydrates and 50%-55% fats) did not decrease insulin sensitivity compared with a control diet (50%-55% D r a f t 16 carbohydrates and 30% fats). Therefore, it is possible that short-term intake of a eucaloric diet containing >70% fats may aggravate postprandial glucose metabolism, whereas a eucaloric diet containing <50% fats may have little effect on the aggravation of postprandial glucose metabolism.
The direct reason for the excessive increase in postprandial glucose concentration after LCHF may be a decrease in postprandial glucose disposal by the suppression of first-phase insulin release. This suppression of first-phase insulin release leads to the reduction of peripheral and hepatic glucose uptake and suppression of hepatic glucose production in the postprandial state. Of note, LCHF was found to reduce the ability of insulin to suppress endogenous glucose production (Bisschop et al. 2001) . Therefore, in the present study, the reduction in the suppression of hepatic glucose production may explain the excessive increase in postprandial glucose concentration after LCHF. On the other hand, the decrease in first-phase insulin release after LCHF appears to be due to prolonged exposure to a high concentration of FFA in blood. The effect of serum FFA on insulin secretion is controversial. Nevertheless, prolonged elevation of serum FFA concentration leads to impaired insulin secretion (Oprescu et al. 2007 ). In the present study, fasting FFA and β-HBA concentrations increased after a 3-day intake of LCHF and were higher than those after a 3-day intake of C. In contrast, fasting FFA D r a f t 17 and β-HBA concentrations remained unchanged after a 3-day intake of ICIF and did not differ from that those after a 3-day intake of C. These results indicate that a 3-d intake of LCHF induced prolonged elevation of serum FFA concentration, which may decrease insulin secretion and consequently increase postprandial glucose concentration excessively.
The iAUC of circulating VCAM-1 concentration was higher after LCHF than after C. To the best of our best knowledge, this is the first evidence of an increase in postprandial VCAM-1 concentration after short-term intake of LCHF, which suggests that even an acute excessive increase in postprandial glucose concentration may cause endothelial activation. In healthy individuals, circulating soluble adhesion molecules have been reported to increase by even acute increases in glucose concentration under normal range of postprandial glucose concentration (peak postprandial glucose concentration: approximately 8mmol/l) (Ceriello et al. 2004; Derosa et al. 2010) . Moreover, the increase in circulating soluble adhesion molecules during acute hyperglycemia has been reported to be regulated by endogenous insulin secretion (Marfella et al. 2000; Perkins et al. 2015) . Therefore, the decrease in first-phase insulin secretion as well as the excessive increase in postprandial glucose concentration after LCHF may have contributed to the increase in circulating VCAM-1 concentration. Unlike the iAUC of circulating VCAM-1 concentration, that of ICAM-1 D r a f t concentration did not differ among the 3 diets. This suggests that circulating VCAM-1 and ICAM-1 concentrations were regulated by different pathways. The underlying mechanism is potentially mediated via advanced glycation end products (AGEs). AGEs form and increase in hyperglycemic environments (Brownlee 1995) and following the 2-h standard meal test (Beisswenger et al. 2001) . The increased postprandial AGEs (methylglyoxal and 3-deoxyglucosone as highly reactive AGE precursors) are highly correlated with postprandial glycemic excursions (Beisswenger et al. 2001) , suggesting that an excessive increase in postprandial glucose concentration after meal ingestion promotes the production of AGEs.
Moreover, increased postprandial AGEs may interact with the endothelial receptors of AGEs and up-regulate the transcription factor NF-κB (Bierhaus et al. 1997; Schmidt et al. 1994) , which may transcribe VCAM-1 and ICAM-1 genes (Basta et al. 2004 ). Although there is no evidence of an association between postprandial AGE and activation of NF-κB, NF-κB can be activated in postprandial state (up to 2 hours after meal ingestion) (Aljada et al. 2004 ).
Furthermore, increased postprandial AGEs affect the postprandial serum VCAM-1 and ICAM-1 concentrations (Negrean et al. 2007) . Considering these facts, it is possible that increased AGEs, due to an excessive increase in postprandial glucose concentration, are involved in the postprandial response of VCAM-1 and ICAM-1 concentrations, mediated by D r a f t 19 the activation of NF-κB. AGEs selectively enhance endothelial VCAM-1 expression, whereas their effect on ICAM-1 has not been observed in vitro (Schmidt et al.1995) . Although ingestion of an AGEs-rich meal acutely increases both postprandial serum VCAM-1 and ICAM-1 concentrations, the postprandial response in serum VCAM-1 appears to be remarkably greater than that in serum ICAM-1 (Negrean et al. 2007) . Therefore, it is speculated that the increase in AGEs via excessive increase in postprandial glucose concentration after a short-term intake of LCHF is involved in the selective increase in the postprandial serum VCAM-1 concentration.
The greater increase in GLP-1 concentration after LCHF was in agreement with the results of previous studies (Numao et al. 2012 (Numao et al. , 2013 . This increase in GLP-1 concentration after a 3-day intake of LCHF may represent a physiological response to enhance insulin secretion for replenishing deficient glucose in various tissues, such as the liver and skeletal muscle. There are several limitations in the present study. First, the participants were young healthy males. Therefore, our findings may not be applicable to older adults or those with impaired glucose tolerance and diabetes. However, it is possible that alterations in postprandial glucose metabolism and circulating soluble adhesion molecules after a short-term intake of LCHF would be greater in such individuals than in young healthy males, because perturbations in postprandial glucose concentration and circulating soluble adhesion molecules are likely to be exaggerated in such individuals. Second, the sample size (n = 7) was smaller than the preliminarily estimated sample size (n =11). Nevertheless, the significant differences observed in the present study were accompanied by a high effect size (Cohen's d >1.26) with adequate statistical power (> 79%). Therefore, our findings on the effects of LCHF on postprandial glucose metabolism and circulating soluble adhesion molecules are reliable.
In conclusion, we observed that short-term intake of eucaloric LCHF aggravated the response D r a f t 21 of postprandial glucose metabolism and circulating VCAM-1 concentration in healthy males, whereas eucaloric ICIF had little effects. Thus, short-term intake of a eucaloric diet containing more than 70% fats may contribute to the development of impaired glucose tolerance, diabetes, and arteriosclerosis in healthy males.
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